Dr rafi hofstein biography
Home / Related Biographies / Dr rafi hofstein biography
R Sameh pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. L Stone Matthew
pediatricsUniversity of Virginia Health System; Charlottesville, VA
United States of America
Dr. He has served as Chairman of the Board of Directors of Hadasit since 2006. A not-for-profit initiative, EXCITE International will succeed through broad-based global collaboration, strong partnerships and its capable leadership and staff.”Dr.
Dr. Hofstein completed postdoctoral training at Harvard Medical School in both the departments of biological chemistry and neurobiology.
Dr. R Ismail, pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatricsKing Abdul Aziz University
United Arab Emirates
Dr.
Hofstein has served on our Board of Directors since 2003, our Audit Committee since 2007, and our Compensation Committee since 2012.
Hofstein was the founder and served as chair of Hadasit BioHolding Ltd., a publicly-traded holding company (10 start-ups under management) on the Tel Aviv Stock Exchange (TASE) since 2005. In addition, Dr. Hofstein is a co-founder and board member of ILSI, the Israeli Life Science Industry Organization, and a co-founder and executive in Israel’s Tech Transfer Network (ITTN).
Government Relations
VC and Private Equity
Corporate Leadership
Research
Capital Markets
Pharmaceuticals
Biotechnology
Non-Profit/Charitable
Medical Devices
Corporate & Business Strategy
Early-Stage Investing
Life Sciences and Healthcare
Technology Transfer
Commercialization of Innovation
Neurobiology Department, Harvard Medical School
Post-Doctoral Training
Molecular Biology and Physiology
Weizmann Institute of Science
PhD
Life Science and Chemistry
Weizmann Institute of Science
Master of Science
Life Sciences and Chemistry
Hebrew University of Jerusalem
Bachelor of Science
Chemistry and Physics
Show All +
Good News for Bad Guts
Yonge Street Mediaprint
2014-11-12
MaRS Innovation-University of Toronto start-up Encycle Therapeutics, is the recipient of a generous grant to further research its development of an oral treatment for inflammatory bowel disease, or IBD--the first of its kind.
As Dr.
Raphael Hofstein, president and CEO of MaRS Innovation, told Drug Discovery and Development: "Encycle Therapeutics has spent the last 18 months demonstrating the significant potential of its innovative macrocyle chemistry platform to generate small-cell permeable systems . Raphael (Rafi) Hofstein joined MaRS Innovation as President and CEO in June 2009.
During the 1980s, Dr Hofstein held the roles of scientific director of Biotechnological Applications Ltd., and manager R&D and chief of Immunochemistry at the International Genetic Scientific Partnership, organizations that were pivotal in developing Israel’s world-leading biotechnology sector.
Dr.
. Other directorships held on TASE publicly-traded companies include: Bioline RX (drug development); Exalenz (medical devices); and Evogene (agri-bio).
He has also served as chairman of BIOMED, Israel’s annual biomedical conference, from 2005 to 2007. Prior to joining Hadasit, Dr. Hofstein was the President of Mindsense Biosystems Ltd.
and the Business Unit Director of Ecogen Inc. and has held a variety of other positions, including Manager of R&D and Chief of Immunochemistry at the International Genetic Science Partnership. From 1999 to the present, he has held the position of president and CEO of Hadasit Ltd., the technology transfer and commercialization company of the Hadassah Medical Organization in Jerusalem.
Raphael (Rafi) Hofstein
Dr. Dr. Hofstein received his PhD and MSc from the Weizmann Institute of Science and his BSc in chemistry and physics from the Hebrew University in Jerusalem.
Dr. Hofstein served as the President and Chief Executive Officer of MaRS Innovation (a commercialization company for 15 of Toronto’s universities, institutions, and research institutes, plus the MaRS Discovery District) from June 2009 to March 2020. Leslie Levin, CEO and Chief Scientific Officer, EXCITE International
Raphael (rafi) Hofstein
Matthew L Stone
pediatricsUniversity of Virginia Health System; Charlottesville, VA
United States of America
Dr.
View More
Show All +
Cracking the innovation code – Creating Canadian value in the global market
Toronto CFO Executive SummitHilton Toronto Markham Suites
2014-12-08
Strengthening the interface between industry and technology transfer offices
AACT Canada ConferenceToronto, ON, Canada
2013-12-05
Shaping our future in the changing global biopharma R&D economy
CQDM Global BioPharma eventMontreal, QC, Canada
2013-06-12
- Keynote
- Moderator
- Panelist
- Workshop Leader
From 1997 to 1999 Dr.
Hofstein was president of Mindsense Biosystems Ltd., an Israeli company that develops neuropsychiatric immune assays.